Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry

Zubin J. Eapen; Sana Al-Khatib; Renato D. Lopes; Yongfei Wang; Haikun Bao; Jeptha Curtis; Paul A. Heidenreich; Adrian F. Hernandez; Eric D. Peterson; Stephen C. Hammill

doi:10.1016/j.jacc.2012.06.024

Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry

Zubin J. Eapen, Sana Al-Khatib, Renato D. Lopes, Yongfei Wang, Haikun Bao, Jeptha Curtis, Paul A. Heidenreich, Adrian F. Hernandez, Eric D. Peterson, Stephen C. Hammill

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	1577-1578
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	60
Issue number	16
DOIs	https://doi.org/10.1016/j.jacc.2012.06.024
State	Published - Oct 16 2012
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2012.06.024

Cite this

Eapen, Z. J., Al-Khatib, S., Lopes, R. D., Wang, Y., Bao, H., Curtis, J., Heidenreich, P. A., Hernandez, A. F., Peterson, E. D., & Hammill, S. C. (2012). Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry. Journal of the American College of Cardiology, 60(16), 1577-1578. https://doi.org/10.1016/j.jacc.2012.06.024

Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry. / Eapen, Zubin J.; Al-Khatib, Sana; Lopes, Renato D. et al.
In: Journal of the American College of Cardiology, Vol. 60, No. 16, 16.10.2012, p. 1577-1578.

Research output: Contribution to journal › Letter › peer-review

Eapen, ZJ, Al-Khatib, S, Lopes, RD, Wang, Y, Bao, H, Curtis, J, Heidenreich, PA, Hernandez, AF, Peterson, ED & Hammill, SC 2012, 'Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry', Journal of the American College of Cardiology, vol. 60, no. 16, pp. 1577-1578. https://doi.org/10.1016/j.jacc.2012.06.024

@article{e4a98119658f4e9eaa6d51a3947f6d5a,

title = "Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry",

author = "Eapen, {Zubin J.} and Sana Al-Khatib and Lopes, {Renato D.} and Yongfei Wang and Haikun Bao and Jeptha Curtis and Heidenreich, {Paul A.} and Hernandez, {Adrian F.} and Peterson, {Eric D.} and Hammill, {Stephen C.}",

note = "Funding Information: Please note: This work was supported by an award from the American Heart Association Pharmaceutical Roundtable and David and Stevie Spina. Dr. Eapen has received funding from an American Heart Association Pharmaceutical Roundtable outcomes training grant ( 0875142N ). Dr. Lopes has received funding for a research grant from Bristol-Myers Squibb (significant). Dr. Al-Khatib has received modest speaking fees from Medtronic Inc. Dr. Curtis has received stock holding in Medtronic Inc. (significant); research funding from Boston Scientific (significant); and salary support from the American College of Cardiology National Cardiovascular Data Registry (significant). Dr. Heidenreich is an uncompensated consultant to Boston Scientific. Dr. Hernandez has received research funding from Johnson & Johnson and Amylin Pharmaceuticals, Inc. (>$10,000) and honorarium from Sanofi Aventis, AstraZeneca, Johnson & Johnson, and Corthera, Inc. (<$10,000). Dr. Peterson has received grant support from Eli Lilly and Company , Johnson & Johnson, and Janssen Pharmaceuticals . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2012",

month = oct,

day = "16",

doi = "10.1016/j.jacc.2012.06.024",

language = "English (US)",

volume = "60",

pages = "1577--1578",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "16",

}

TY - JOUR

T1 - Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry

AU - Eapen, Zubin J.

AU - Al-Khatib, Sana

AU - Lopes, Renato D.

AU - Wang, Yongfei

AU - Bao, Haikun

AU - Curtis, Jeptha

AU - Heidenreich, Paul A.

AU - Hernandez, Adrian F.

AU - Peterson, Eric D.

AU - Hammill, Stephen C.

N1 - Funding Information: Please note: This work was supported by an award from the American Heart Association Pharmaceutical Roundtable and David and Stevie Spina. Dr. Eapen has received funding from an American Heart Association Pharmaceutical Roundtable outcomes training grant ( 0875142N ). Dr. Lopes has received funding for a research grant from Bristol-Myers Squibb (significant). Dr. Al-Khatib has received modest speaking fees from Medtronic Inc. Dr. Curtis has received stock holding in Medtronic Inc. (significant); research funding from Boston Scientific (significant); and salary support from the American College of Cardiology National Cardiovascular Data Registry (significant). Dr. Heidenreich is an uncompensated consultant to Boston Scientific. Dr. Hernandez has received research funding from Johnson & Johnson and Amylin Pharmaceuticals, Inc. (>$10,000) and honorarium from Sanofi Aventis, AstraZeneca, Johnson & Johnson, and Corthera, Inc. (<$10,000). Dr. Peterson has received grant support from Eli Lilly and Company , Johnson & Johnson, and Janssen Pharmaceuticals . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2012/10/16

Y1 - 2012/10/16

UR - http://www.scopus.com/inward/record.url?scp=84867400776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867400776&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2012.06.024

DO - 10.1016/j.jacc.2012.06.024

M3 - Letter

C2 - 22958954

AN - SCOPUS:84867400776

SN - 0735-1097

VL - 60

SP - 1577

EP - 1578

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 16

ER -

Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing? An analysis of 107,096 patients from the national cardiovascular data registry's ICD registry

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this